Literature DB >> 15001202

Regulation of parathyroid hypertensive factor secretion by Ca2+ in spontaneously hypertensive rat parathyroid cells.

Sharla K Sutherland1, Christina G Benishin.   

Abstract

BACKGROUND: Elevated parathyroid hypertensive factor (PHF) has been suggested to play a causal role in the pathogenesis of hypertension. Previous studies have indicated that PHF secretion is stimulated by low extracellular (EC) Ca2+. Therefore, we hypothesized that the calcium-sensing receptor (CaR) is involved in regulation of PHF release.
METHODS: Parathyroid gland (PTG) organ and cell cultures derived from spontaneously hypertensive rats (SHR) or Wistar-Kyoto (WKY) rats were exposed to low and normal EC Ca2+ and PHF release measured by ELISA. Expression of CaR protein was assessed by Western blot.
RESULTS: Low EC Ca2+ stimulated both SHR and WKY PTG organ cultures to secrete more PHF, first observable after 60 min incubation. After 4 h, PHF secretion was stimulated (66-fold v 24-fold stimulation for SHR and WKY, respectively). Cultured SHR and WKY parathyroid cells were also stimulated, but to a lesser extent (2.63-fold v 3.75-fold stimulation for SHR and WKY respectively). After 24 h the stimulation by low EC Ca2+ was no longer apparent. Expression of CaR is elevated in the SHR relative to WKY PTG. In both strains expression is higher under conditions of normal (1.5 mmol/L) EC Ca2+ and it increases with incubation time. The apparent suppression of PHF release by normal (1.5 mmol/L) EC Ca2+ is blocked by pre-exposure of the PTG cells to anti-CaR antibody.
CONCLUSIONS: Low EC Ca2+ stimulated rapid PHF release from both SHR and WKY PTG. Changes in CaR expression may account for different sensitivity to EC Ca2+ of the two strains and over time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001202     DOI: 10.1016/j.amjhyper.2003.11.010

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

Review 1.  The calcium-sensing receptor and calcimimetics in blood pressure modulation.

Authors:  Sanela Smajilovic; Shozo Yano; Reza Jabbari; Jacob Tfelt-Hansen
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in rats.

Authors:  Kumiko Nakagawa; Niru Parekh; Nadezda Koleganova; Eberhard Ritz; Franz Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

3.  Calcimimetic R-568 and its enantiomer S-568 increase nitric oxide release in human endothelial cells.

Authors:  Mario Bonomini; Annalisa Giardinelli; Caterina Morabito; Sara Di Silvestre; Moreno Di Cesare; Natalia Di Pietro; Vittorio Sirolli; Gloria Formoso; Luigi Amoroso; Maria Addolorata Mariggiò; Assunta Pandolfi
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

4.  CaSR participates in the regulation of vascular tension in the mesentery of hypertensive rats via the PLC‑IP3/AC‑V/cAMP/RAS pathway.

Authors:  Wenwen Zhang; Ruixia Sun; Hua Zhong; Na Tang; Yongmin Liu; Yongli Zhao; Tian Zhang; Fang He
Journal:  Mol Med Rep       Date:  2019-08-27       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.